Page 1914 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1341

Health-related quality of life (HRQoL), Hemofiltration, 1206 Heparin-induced thrombocytopenia (HIT),
104–105 Hemoglobin, 842 327, 851–852, 851t
neuropsychological morbidities and, Hemoglobinopathy, 999 in burn patients, 1187
105–106 Hemolysis, elevated liver enzymes, diagnosis of, 328
Heart low platelets syndrome Heparin-like compounds, 854
compression of, by surrounding (HELLP), 856 Heparin necrosis, 328
structures, 259 Hemolytic uremic syndrome (HUS), 852–853, Hepatic abscess, 1082
Starling curve of, 230–231, 230f 858, 860–861, 860f, 861f, 926 Hepatic biotransformation, 1232, 1232t,
Heart disease, sickle cell disease and, diagnosis of, 861–863 1233t, 1234–1238, 1234t,
906–907 differentiation of thrombotic 1235ft, 1236t
Heart transplantation, 1102–1108 thrombocytopenic purpura from, Hepatic encephalopathy, 1027, 1027t
indications and outcomes, 1102 862–863, 862t Hepatic hydrothorax, 1028–1029
infectious complications, 1104–1107, management of organ failure and Hepatic toxicities, 897–898
1105ft, 1107t treatment-related complications, Hepatic venoocclusive disease, 888
postoperative complications, 864–865 Hepatitis, hypoxic, 1023
1103–1104, 1104t treatment of, 863–864 Hepatitis A, 676
postoperative management, 1102–1103 Hemoperfusion, 1206 Hepatitis B virus (HBV), infection
procedures, 1102 Hemoperitoneum, 1161 control and, 30, 676
Heat stroke, 560 Hemopneumothorax, simple, 1160 Hepatitis C virus (HCV), infection
Heliox, 500–501 Hemoptysis, massive, 214, 874. See also control and, 30
for noninvasive ventilation, 381 Massive hemoptysis Hepatobiliary iminodiacetic scintigraphy
HELLP syndrome, 985 Hemorrhage. See also Bleeding (HIDA scan), 559
Hematomas acute variceal, 1030–1031 Hepatobiliary system, sickle cell disease
aortic intramural, 357 alveolar, 895 and, 907
epidural, 1122 diffuse alveolar, 887 Hepatocellular carcinoma, 1101
subdural, 1122 gastrointestinal, 1008–1021 Hepatopulmonary syndrome (HPS), 223,
Hematopoietic cell dysfunction in sepsis, 566 clinical considerations, 1028, 1101–1102
Hematopoietic growth factors, role of, in 1009–1010, 1009t Hepatorenal syndrome (HRS), 223,
management of febrile neutropenic lower, 1018–1020, 1019f 927, 1029
patients, 613 nonvariceal, 1014–1018 Hepatosplenic candidiasis, 618
Hematopoietic stem cell transplantation, upper, 1010 Hepatotoxicity, 898
graft-versus-host disease and, variceal, 1010–1014 Hereditary angioedema (HAE), 409
881–890, 882ft intracerebral, 775, 776t Hereditary thrombotic thrombocytopenic
complications of conditioning regimen, intracranial, 876–877, 876t purpura, 858
882–883 intrathoracic, 1158 Herniation, transcalvarial, 1123
general and critical care outcomes in HSCT locating source of internal, 1119 Herniation syndromes, 790, 795–797,
recipients, 890 lower gastrointestinal, 1018–1020, 1019f 795ft, 796ft, 797f
hepatic complications, 888–889 nonvariceal, 1014–1018 Herpes B virus, 671
infectious complications, 885–886, 886t postoperative, and sentinel bleed, 1067 Herpes simplex, 1300, 1300ft, 1301f
pulmonary complications, 886–888 retroperitoneal, 1166 Herpes simplex virus (HSV), 676
rejection/graft failure, 889 splinter, 1299 as cause of nonepidemic fatal
relapses, 890 spontaneous subarachnoid, 771 encephalitis, 665
renal complications, 889 subarachnoid, 1123, 1123f Herpes simplex virus encephalitis (HSVE),
Hematuria, 1166 due to ruptured intracranial aneurysm, 666, 669, 705
Hemobilia, 1021 775–778 clinical features and diagnosis of,
Hemodialysis, 1205–1206 upper gastrointestinal, 1010 666, 669f, 670f
Hemodynamic instability, management variceal, 1010–1014 epidemiology and pathogenesis, 666
of, 1145 acute, 1030–1031 management of, 666, 669
Hemodynamic monitoring, 296–297, 296t endoscopic therapy, 1012–1013 Herpes simplex virus type 2 (HSV2)
functional, 248 management, 1010–1012, 1011ft encephalitis, 669–670
head injury and, 1126–1127, 1126f, 1127f pharmacotherapy, 1012 Herpes viridae, encephalitis and, 666,
in sepsis, 569, 572–573 salvage therapy for endoscopically 669–671
Hemodynamic stability, maintaining, uncontrolled bleeding, 1009–1010 Hetastarch, 572
839–840 Hemorrhagic diarrhea, 707 Heterotopic ossification, 109, 109f
Hemodynamic waveforms Hemorrhagic fever Heyde syndrome, 854
clinical use of pressure measurements, approach to patients with, 743 High airway pressures/large tidal
195–201, 195f, 196f, 197f, 198f, 199f, with renal syndrome, 742–743 volumes and lung injury,
200f, 201f Hemorrhagic shock in pregnancy, 441–442, 441f, 442f
interpretation of, 186–202 1257–1259, 1258t High cardiac output hypotension, 259
pressure monitoring system, 186–187, 187f Hemothorax, 507 High-dose cytarabine (HDARA-C), 603
pressure, 187, 188f, 189f Heparin, 304, 327, 854, 1285 High-frequency oscillatory ventilation, 436
pulmonary artery, 190–192, 191f alternatives to, 328–329 High-intensity staffing model, 12
pulmonary artery wedge, 192–193, 192f, complications of, 327–328 High-output cardiac failure, 275
193f discontinuation of, in interventional High-pressure pulmonary edema, 384
right atrial, 187, 190, 190f radiology, 209 High-risk situations in developing
transmural, 193–195, 194f low-molecular-weight, 328 psychological problems, 117

Index.indd 1341 23-01-2015 15:33:52